Sales run-rate for April encouraging
20/05/20 -"H2 was better than expectations, led by a sturdy show in wholesale, though retail and cochlear implants lost pace due to the ongoing pandemic. Higher volumes and ASPs bolstered EBITA, though these ..."
Pages
61
Language
English
Published on
20/05/20
You may also be interested by these reports :
18/03/24
DiaSorin’s 2023 results were in line with street expectations, however the profitability guidance miss disappointed investors. Healthy performance by ...
14/03/24
Q4 sales met the street’s expectations. Industrial Applications reported strong growth and Clinical Applications ended on a decent note, despite ...
12/03/24
First take: Growing profitability with 3-18% beat on expectations
08/03/24
When we last teased on Elekta’s (BUY; Sweden) investment case in October 2022, Elekta grabbed the investors’ much-needed attention (up >35% since ...